[Federal Register Volume 87, Number 102 (Thursday, May 26, 2022)]
[Notices]
[Page 32032]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-11335]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Eye Institute Special Emphasis 
Panel; NEI RFA: Age-related Macular Degeneration (AMD) Integrative 
Biology Initiative: Discovery of AMD Pathobiology using Patient-
Derived Induced Pluripotent Stem Cell-derived Retinal Pigment 
Epithelium.
    Date: May 26, 2022.
    Time: 10:00 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Eye Institute, National Institutes of Health, 
6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, National Eye Institute, National Institutes of Health, 
6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892, 240-276-5864, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.867, 
Vision Research, National Institutes of Health, HHS)

    Dated: May 22, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-11335 Filed 5-25-22; 8:45 am]
BILLING CODE 4140-01-P